May 8 (Reuters) - Kenvue ( KVUE ) beat analysts'
expectations for first-quarter profit and revenue on Thursday,
as strong demand for its self-care products including cough and
cold medicines Tylenol and Benadryl helped offset a fall in
demand for its skin health and beauty products.